A. . Blauvelt, “Long-Term Improvements Observed in Tralokinumab-Treated Patients with Moderate-to-Severe Atopic Dermatitis: an ECZTEND Interim Analysis”, J of Skin, vol. 5, no. 6, p. s59, Nov. 2021.